INDEGENE LIMITED-IPO -TO OPEN ON MAY,06,2024.PRICE BAND FIXED AT Rs.430/-per Equity Share TO Rs.452/- per EQUITY SHARE.

INDEGENE LIMITED: Helps Bio Pharmaceutical,emerging Bio Tech & Medical device Companies to develop products,get them to the market and grow their impact through the life cycle in a more effective,efficient &modern way.The Company's focus is on modernising healthcare operations by applying deep medical science expertise and fit-for-purpose Technology.
To quote Mr.Manish Gupta, Chairman & Chief Executive Officer of Indegene Ltd., "From our founding days,we focused on building a global differentiated organization,dedicated to cutting edge technology & contemporary practices to modernize healthcare." The Company works at the convergence of Two exciting industries healthcare & Technology.

The Company has 17 offices worldwide.

About the IPO: * Price band fixed at Rs.430/- per equity share to Rs.452/- per equity share of Face value of Rs.2/-each of Indegene Ltd.

* Anchor Investor Bidding date : May,03,2024.

* Bid/offer Opening  date : May,06,2024.

* Bid/Offer Closing Date : May,08,2024.

* Bids can be made for a minimum of 33 equity shares and in multiples of 33 equity shares thereafter.

* The Floor price is 215 times and the Cap price is 226 times the face value of the equity shares.

The Company intends to use the proceeds of the fresh issue utilize towards funding the Repayment/prepayment of indebtedness of one of its Material subsidiaries,ILSL Holdings,Inc.funding the capital expenditure requirements of the company and one of its Material Subsidiaries,Indegene Inc.as well as funding the general corporate purposes and inorganic growth.

Listing: The Equity shares offered through the Red Herring Prospectus is proposed to be listed on BSE and NSE.

Merchant Bankers : Kotak Mahindra Capital Company Ltd., Citigroup Global Markets India Private Ltd.,JP Morgan India Private Ltd., and Nomura Financial Advisory & Securities (India)Private Ltd.,are the book running Lead Managers to the Offer.

The investors are advised to go through the details of the IPO before taking a decision to invest.